Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 76 14190 093130 270201 271201 271-
Entreprise Value (EV)1 95 814106 980145 623213 439208 329206 333
P/E ratio 34,0x30,9x35,4x33,1x30,5x30,8x
Yield 0,32%0,30%0,23%0,17%0,20%0,21%
Capitalization / Revenue 3,64x3,70x5,10x6,49x6,00x5,93x
EV / Revenue 4,58x4,39x5,70x6,88x6,21x6,08x
EV / EBITDA 18,1x17,4x22,3x21,8x20,2x20,3x
Price to Book 3,00x3,26x4,38x6,05x5,24x4,93x
Nbr of stocks (in thousands) 400 995402 576400 991396 335396 335-
Reference price (USD) 190224325508508508
Last update 01/31/201801/30/201901/30/202001/19/202101/19/202101/19/2021
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 20 91824 35825 54231 01233 54433 921
EBITDA1 5 2996 1416 5379 81210 31110 145
Operating profit (EBIT)1 4 8605 6155 9739 0909 5529 338
Operating Margin 23,2%23,1%23,4%29,3%28,5%27,5%
Pre-Tax Profit (EBT)1 2 4293 2624 0706 4797 0608 391
Net income1 2 2252 9383 6966 0766 4746 406
Net margin 10,6%12,1%14,5%19,6%19,3%18,9%
EPS2 5,597,249,1715,316,616,5
Dividend per Share2 0,600,680,760,851,001,06
Last update 01/31/201801/30/201901/30/202001/26/202101/26/202101/26/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 19 67316 88715 35312 1687 0585 062
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,71x2,75x2,35x1,24x0,68x0,50x
Free Cash Flow1 3 4973 7854 0475 6557 1587 124
ROE (Net Profit / Equities) 16,1%17,0%17,4%23,5%22,2%21,0%
Shareholders' equity1 13 83717 25921 26925 82629 17630 465
ROA (Net Profit / Asset) 7,37%8,00%8,70%11,9%11,3%11,0%
Assets1 30 20636 74842 50251 27757 42158 237
Book Value Per Share2 63,368,674,284,096,8103
Cash Flow per Share2 10,111,212,318,921,020,5
Capex1 5087589261 3671 2191 148
Capex / Sales 2,43%3,11%3,63%4,41%3,64%3,39%
Last update 01/31/201801/30/201901/30/202001/19/202101/22/202101/22/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
201 270 900 045
Net sales (USD)
25 542 000 000
Number of employees
75 000
Sales / Employee (USD)
340 560
Free-Float
90,6%
Free-Float capitalization (USD)
182 371 922 665
Avg. Exchange 20 sessions (USD)
797 025 169
Average Daily Capital Traded
0,40%
EPS & Dividend